后急性COVID-19综合征的认知障碍:一个范围审查
Gabriela Cabett Cipolli1, Vanessa Alonso1, Clarissa Lin Yasuda2
1Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Programa de Pós-graduação em Gerontologia, Campinas SP, Brazil.
Arquivos de neuro-psiquiatria
|December 29, 2023
概括
后COVID-19认知障碍影响语言,记忆和执行功能在亚急性阶段. 慢性症状会影响成人的注意力,记忆力和执行功能.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 认知科学 认知科学
背景情况:
- 经过急性COVID-19感染后的持续症状越来越多地被识别出来.
- 认知缺陷在COVID-19后的一些个人中是显著的后果.
- 关于受影响的特定认知领域和疾病严重程度的影响,人们的理解有限.
研究的目的:
- 系统地审查和分类后急性COVID-19综合征的认知障碍.
- 为了区分症状的亚急性和慢性阶段的认知改变.
- 确定受COVID-19影响的特定认知领域.
主要方法:
- 按照乔安娜·布里格斯研究所 (JBI) 的指导方针进行范围审查的方法.
- 在主要数据库 (PubMed,Embase,SCOPUS等) 进行全面的文献搜索. 从2019年12月开始到2022年12月.
- 包括和数据提取侧重于人口,背景,概念和与认知障碍相关的发现.
主要成果:
- 分析了来自 7,540 个识别记录的 47 项研究.
- 亚急性阶段 (感染后4-12周):最常见的语言,情节性记忆和执行功能障碍.
- 慢性阶段 (>感染后12周):注意力,情节性记忆和执行功能是受影响最严重的领域.
结论:
- 经历后急性COVID-19综合征的成年人经常表现出特定的认知领域障碍.
- 认知缺陷在疾病的亚急性和慢性阶段之间有所不同.
- 需要进一步的研究来了解COVID-19后认知功能障碍的轨迹和机制.
相关概念视频
01:30Negative and Cognitive Symptoms of Schizophrenia
48
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48
01:30Cognitive Development During Adulthood
114
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
114
01:30Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
01:26Alzheimer's Disease: Overview
491
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
491
01:03Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
127
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
127